Last reviewed · How we verify

Xe 127 — Competitive Intelligence Brief

Xe 127 (xenon (127Xe) gas) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Inhalation Diagnostic Agent. Area: Respiratory.

marketed Inhalation Diagnostic Agent Respiratory Live · refreshed every 30 min

Target snapshot

Xe 127 (xenon (127Xe) gas).

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Xe 127 TARGET xenon (127Xe) gas marketed Inhalation Diagnostic Agent 1982-01-01
XENON XE 133 XENON XE 133 marketed Inhalation Diagnostic Agent [EPC] 1982-01-01
Xe 133 xenon (133Xe) gas Mallinckrodt marketed Inhalation Diagnostic Agent [EPC]

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Inhalation Diagnostic Agent class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Xe 127 — Competitive Intelligence Brief. https://druglandscape.com/ci/xenon-127xe-gas. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: